162 related articles for article (PubMed ID: 37975819)
1. Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy.
Kampouri E; Ibrahimi SS; Xie H; Wong ER; Hecht JB; Sekhon MK; Vo A; Stevens-Ayers TL; Green DJ; Gauthier J; Maloney DG; Perez A; Jerome KR; Leisenring WM; Boeckh MJ; Hill JA
Clin Infect Dis; 2024 Apr; 78(4):1022-1032. PubMed ID: 37975819
[TBL] [Abstract][Full Text] [Related]
2. Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma.
Josyula S; Pont MJ; Dasgupta S; Song X; Thomas S; Pepper G; Keane-Candib J; Stevens-Ayers TL; Ochs HD; Boeckh MJ; Riddell SR; Cowan AJ; Krantz EM; Green DJ; Hill JA
Transplant Cell Ther; 2022 Jun; 28(6):304.e1-304.e9. PubMed ID: 35288345
[TBL] [Abstract][Full Text] [Related]
3. Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy.
Hill JA; Kiem ES; Bhatti A; Liu W; Keane-Candib J; Fitzpatrick KS; Boonyaratanakornkit J; Gardner RA; Green DJ; Maloney DG; Turtle CJ; Smith JM; Gimferrer I; Blosser CD; Jackson SW
Am J Transplant; 2023 Mar; 23(3):416-422. PubMed ID: 36748802
[TBL] [Abstract][Full Text] [Related]
4. Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy.
Hill JA; Krantz EM; Hay KA; Dasgupta S; Stevens-Ayers T; Bender Ignacio RA; Bar M; Maalouf J; Cherian S; Chen X; Pepper G; Riddell SR; Maloney DG; Boeckh MJ; Turtle CJ
Blood Adv; 2019 Nov; 3(22):3590-3601. PubMed ID: 31743392
[TBL] [Abstract][Full Text] [Related]
5. Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial.
Jarque M; Crespo E; Melilli E; Gutiérrez A; Moreso F; Guirado L; Revuelta I; Montero N; Torras J; Riera L; Meneghini M; Taco O; Manonelles A; Paul J; Seron D; Facundo C; Cruzado JM; Gil Vernet S; Grinyó JM; Bestard O
Clin Infect Dis; 2020 Dec; 71(9):2375-2385. PubMed ID: 32076718
[TBL] [Abstract][Full Text] [Related]
6. Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy.
Márquez-Algaba E; Iacoboni G; Pernas B; Esperalba J; Los Arcos I; Navarro V; Monforte A; Beas F; Albasanz-Puig A; Carpio C; Barba P; Ruiz-Camps I
Transplant Cell Ther; 2022 Dec; 28(12):851.e1-851.e8. PubMed ID: 36221995
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
8. Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation.
Valle-Arroyo J; Páez-Vega A; Fernández-Moreno R; López-Jiménez J; Luna A; Duarte R; Serrano-Martínez F; Villar S; Fernández-Alonso M; Reina G; González-Rico C; Fariñas MC; Rojas R; Herrera C; Martín C; García-Torres E; Torre-Cisneros J; Cantisán S
Transplant Cell Ther; 2022 Oct; 28(10):703.e1-703.e8. PubMed ID: 35830929
[TBL] [Abstract][Full Text] [Related]
9. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
El Haddad L; Ariza-Heredia E; Shah DP; Jiang Y; Blanchard T; Ghantoji SS; El Chaer F; El-Haddad D; Prayag A; Nesher L; Rezvani K; Shpall E; Chemaly RF
J Infect Dis; 2019 Feb; 219(6):898-907. PubMed ID: 30295846
[TBL] [Abstract][Full Text] [Related]
10. Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
Banas B; Steubl D; Renders L; Chittka D; Banas MC; Wekerle T; Koch M; Witzke O; Mühlfeld A; Sommerer C; Habicht A; Hugo C; Hünig T; Lindemann M; Schmidt T; Rascle A; Barabas S; Deml L; Wagner R; Krämer BK; Krüger B
Transpl Int; 2018 Apr; 31(4):436-450. PubMed ID: 29284181
[TBL] [Abstract][Full Text] [Related]
11. Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation.
Alfaro R; Rodríguez-Aguilar L; Llorente S; Jimenez-Coll V; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Muro-Perez M; Minguela A; Legaz I; Muro M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445668
[TBL] [Abstract][Full Text] [Related]
12. Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunity.
Jorgenson MR; Kleiboeker H; Garg N; Parajuli S; Mandelbrot DA; Odorico JS; Saddler CM; Smith JA
Transpl Infect Dis; 2022 Feb; 24(1):e13766. PubMed ID: 34799964
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.
San-Juan R; Navarro D; García-Reyne A; Montejo M; Muñoz P; Carratala J; Len O; Fortun J; Muñoz-Cobo B; Gimenez E; Eworo A; Sabe N; Meije Y; Martín-Davila P; Andres A; Delgado J; Jimenez C; Amat P; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Aguado JM;
Transpl Infect Dis; 2015 Oct; 17(5):637-46. PubMed ID: 26134282
[TBL] [Abstract][Full Text] [Related]
14. CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.
Jarque M; Melilli E; Crespo E; Manonelles A; Montero N; Torras J; Cruzado JM; Luque S; Gil-Vernet S; Grinyó JM; Bestard O
Transplantation; 2018 Nov; 102(11):e472-e480. PubMed ID: 30130330
[TBL] [Abstract][Full Text] [Related]
15. Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
Kampouri E; Little JS; Rejeski K; Manuel O; Hammond SP; Hill JA
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14157. PubMed ID: 37787373
[TBL] [Abstract][Full Text] [Related]
16. Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
Seo E; Choi ES; Kim JH; Kim H; Koh KN; Im HJ; Lee J
PLoS One; 2021; 16(2):e0246191. PubMed ID: 33544726
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Fatal cytomegalovirus pneumonia after CAR-T cell therapy in the long-term follow-up.
Cheng J; Huang J; Cao W; Huang L; Mao X; Chen L; Zhou J; Wang N
Front Immunol; 2023; 14():1226148. PubMed ID: 37849765
[TBL] [Abstract][Full Text] [Related]
18. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM;
Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation.
Páez-Vega A; Cantisán S; Agüera ML; Suñer M; Facundo C; Yuste JR; Fernández-Ruiz M; Montejo M; Redondo-Pachón D; López-Oliva MO; Fernández-Rodríguez A; Fariñas MC; Hernández D; Len O; Muñoz P; Valle-Arroyo J; Rodelo-Haad C; Cordero E; Torre-Cisneros J
J Infect Dis; 2021 Apr; 223(7):1205-1213. PubMed ID: 32779713
[TBL] [Abstract][Full Text] [Related]
20. Role of cytomegalovirus specific cell-mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single-center experience.
Bhugra A; Khodare A; Agarwal R; Pamecha V; Gupta E
Transpl Infect Dis; 2023 Feb; 25(1):e14011. PubMed ID: 36602403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
